CRON · Cronos Group Inc. · Financials
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | $3.51M | $2.75M | $1.8M | $814K | $646K | $546K | $0 | |
| $1.51M | $2.04M | $630K | $1.52M | $3.55M | $0 | $0 | $5.33M | — | — | |
| $84.55M | $80.15M | $101.73M | $96.71M | $126.86M | $274.38M | $193.55M | $135.72M | $26.66M | $7.7M | |
| — | — | — | — | $13K | $27K | $186K | $1.24M | $139K | $101K | |
| — | — | — | — | $22.55M | $9.1M | $18.6M | $29.21M | $220K | $4000 | |
| $70.9M | $275K | $113.12M | $11.13M | -$9.58M | $163.46M | $146.11M | $1.32B | -$478K | $3.78M | |
| — | $0 | $2.37M | $1.58M | $3.11M | -$6.31M | -$4.51M | -$2.01M | -$723K | $127K | |
| -$2.85M | -$446K | -$3.84M | -$10.51M | $17.85M | $1.97M | -$4.51M | — | — | — | |
| $9.23M | $6.52M | -$1.06M | -$590K | $0 | -$1.1M | -$2.13M | -$932K | -$181K | $0 | |
| -$309.84M | — | — | — | — | — | -$72.49M | $1.17B | -$20.74M | -$1.48M | |
| $22.66M | $37.24M | -$43.12M | -$52.49M | -$219.4M | -$389.24M | -$57.98M | $1.2B | -$33.96M | $1.38M | |
| USD/shares | $0.19 | -$0.02 | $0.11 | -$0.19 | -$0.45 | -$1.07 | -$0.21 | $3.76 | -$0.12 | -$0.01 |
| USD/shares | $0.19 | -$0.02 | $0.11 | -$0.19 | -$0.45 | -$1.07 | -$0.21 | $3.33 | -$0.12 | -$0.01 |
| shares | — | 383.47M | 382.06M | 380.96M | 376.96M | 370.39M | 351.58M | 310.07M | 172.27M | 134.8M |
| shares | — | 383.47M | 385.56M | 380.96M | 376.96M | 370.39M | 351.58M | 342.81M | 172.27M | 176.79M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $9.74M in buybacks.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 46 similar-size Drug Manufacturers - Specialty & Generic companies (of 100 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Rest of World Segment | $86,749,000 | $64,561,000 | $37,224,000 | $20,386,000 | $12,121,000 |
| United States Segment | $5,155,000 | $9,874,000 | $9,495,000 | $3,364,000 | $0 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Canada | $90,330,000 | $82,437,000 | $64,702,000 | $56,233,000 | $50,294,000 | $34,538,000 | $20,202,000 |
| Israel | $41,796,000 | $28,368,000 | $21,134,000 | $30,516,000 | $13,376,000 | $2,539,000 | — |
| Other Countries | $14,461,000 | $6,810,000 | $1,405,000 | $0 | $891,000 | $147,000 | $184,000 |
| United States | — | — | — | — | — | $9,495,000 | $3,364,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cannabis Flower | $108,476,000 | $87,912,000 | $62,070,000 | $63,593,000 | $55,194,000 | $27,932,000 | $15,020,000 | $9,210,000 |
| Cannabis Extracts | $37,700,000 | $29,168,000 | $24,569,000 | $22,522,000 | $8,807,000 | $18,254,000 | $8,702,000 | $2,732,000 |
| Product And Service Other | $411,000 | $535,000 | $602,000 | $634,000 | $560,000 | $533,000 | $28,000 | $179,000 |